AR026704A1 - CRYSTAL FORM - Google Patents
CRYSTAL FORMInfo
- Publication number
- AR026704A1 AR026704A1 ARP000106383A ARP000106383A AR026704A1 AR 026704 A1 AR026704 A1 AR 026704A1 AR P000106383 A ARP000106383 A AR P000106383A AR P000106383 A ARP000106383 A AR P000106383A AR 026704 A1 AR026704 A1 AR 026704A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- refers
- pharmaceutically acceptable
- crystalline form
- solvate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000012453 solvate Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000030159 metabolic disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 4-tert-butoxycarbonylaminophenyl Chemical group 0.000 abstract 1
- 208000031773 Insulin resistance syndrome Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a las formas cristalinas del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi}fenil}-(S)-2-etoxi propanoico, segunformula (1) o su sal farmacéuticamente aceptable, y cualquiera de sus solvatos. La presente también se refiere a los métodos para tratar una o más enfermedadesmetabolicas, particularmente aquellas asociadas con el Síndrome de Resistencia a la Insulina, y el uso de la forma cristalina del compuesto, o su salfarmacéuticamente aceptable, o su solvato , para la fabricacion de un medicamento para uso terapéutico en una o más enfermedades metabolicas. La presente ademásse refiere a las composiciones farmacéuticas que contienen a la forma cristalina del compuesto, o su sal farmacéuticamente aceptable , o su solvato, comoingrediente activo, así como también a los procesos para la fabricacion de la forma cristalina del compuesto, o su sal farmacéuticamente aceptable, o susolvato.This refers to the crystalline forms of the compound 3- {4- [2- (4-tert-butoxycarbonylaminophenyl) ethoxy} phenyl} - (S) -2-ethoxy propanoic acid, according to formula (1) or its pharmaceutically acceptable salt, and any of his solvates. This also refers to methods for treating one or more metabolic diseases, particularly those associated with Insulin Resistance Syndrome, and the use of the crystalline form of the compound, or its pharmaceutically acceptable, or solvate, for the manufacture of a medication for therapeutic use in one or more metabolic diseases. The present invention also refers to pharmaceutical compositions containing the crystalline form of the compound, or its pharmaceutically acceptable salt, or its solvate, as an active ingredient, as well as the processes for the manufacture of the crystalline form of the compound, or its pharmaceutically salt. acceptable, or susolvato.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904417A SE9904417D0 (en) | 1999-12-03 | 1999-12-03 | Crystalline form |
| SE0001422A SE0001422D0 (en) | 2000-04-17 | 2000-04-17 | Crystalline form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026704A1 true AR026704A1 (en) | 2003-02-26 |
Family
ID=26655079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106383A AR026704A1 (en) | 1999-12-03 | 2000-12-01 | CRYSTAL FORM |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR026704A1 (en) |
| AU (1) | AU2034601A (en) |
| WO (1) | WO2001040165A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| AU749505B2 (en) | 1997-10-27 | 2002-06-27 | Dr. Reddy's Laboratories Limited | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| WO1999016758A1 (en) | 1997-10-27 | 1999-04-08 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| AU752059B2 (en) | 1997-10-27 | 2002-09-05 | Dr. Reddy's Laboratories Limited | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| JP2002528535A (en) | 1998-10-29 | 2002-09-03 | ドクター・レディーズ・リサーチ・ファウンデーション | An improved method for producing new antidiabetic agents |
| US6897199B2 (en) | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA26634A1 (en) * | 1998-06-04 | 2004-12-20 | Astra Ab | NOVEL 3-ARYL PROPIONIC ACID DERIVATIVES AND THE LIKE |
| SE9801990D0 (en) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
-
2000
- 2000-11-29 WO PCT/SE2000/002379 patent/WO2001040165A1/en not_active Ceased
- 2000-11-29 AU AU20346/01A patent/AU2034601A/en not_active Abandoned
- 2000-12-01 AR ARP000106383A patent/AR026704A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2034601A (en) | 2001-06-12 |
| WO2001040165A1 (en) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029412A1 (en) | CRYSTAL FORM | |
| CL2004000382A1 (en) | TETRAHYDROISOQUINOLINAS REPLACED, PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT AND PREVENTION OF PATHOLOGICAL STATES THAT ARE RELIEFED WITH A 5-HT6 AGONIST. | |
| ECSP055774A (en) | NEW MEDICATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | |
| AR077478A2 (en) | DERIVATIVES OF OXINDOL REPLACED DRUGS THAT UNDERSTAND AND USE THEMSELVES | |
| UY28510A1 (en) | CHEMICAL COMPOUNDS | |
| ECSP066950A (en) | ADRENOCEPTOR-BETA2 GLICOPIRROLATE AND AGONIST COMBINATIONS | |
| CO5271715A1 (en) | 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS | |
| ATE495155T1 (en) | HETEROCYCLIC INHIBITORS OF MEK | |
| AR057712A1 (en) | DIHYDROPTERIDINONES IN THE TREATMENT OF RESPIRATORY DISEASES | |
| AR029766A1 (en) | QUINASE INHIBITOR COMPOUND AND USE OF IT TO PREPARE A PHARMACEUTICAL COMPOSITION | |
| UY30316A1 (en) | SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS | |
| AR029211A1 (en) | DERIVATIVES OF OXAZOLES, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM | |
| AR029456A1 (en) | SHREDDED FORM | |
| NO20065904L (en) | Therapeutic compounds | |
| AR054347A1 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| AR056575A1 (en) | COMPOSITE OF (ALPHA) -AMINOCARBOXYAMIDE THAT IS 5- (4 - [[(2-FLUOROPHENYL) METHYL] OXI] PHENYL) PROLINAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE IT | |
| ATE331711T1 (en) | ANTI-INFLAMMATORY 3-ARYLTHIO-3-THIAZOLYLALKYLAMINE | |
| UY27018A1 (en) | PIRIMIDINE DERIVATIVES | |
| AR026704A1 (en) | CRYSTAL FORM | |
| UY27959A1 (en) | NEW AGARIST PPAR ALFA AND PPAR RANGE | |
| ES2129448T3 (en) | USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS. | |
| AR001769A1 (en) | Benzamide enterokinetics pharmaceutical compositions containing them, a process for the preparation of said pharmaceutical compositions, the use of said compounds for the manufacture of medicines and a process for their preparation. | |
| AR042547A1 (en) | USE OF ALPHA - PHENYLTIOCABOXYL AND ALPHA - PHENYLOXYCARBOXYL ACIDS WITH DECREASING ACTIVITY OF GLUCOSE IN THE SERUM AND LIPIDS IN THE SERUM | |
| AR026705A1 (en) | SHREDDED FORM | |
| UY27074A1 (en) | AMINOTRIAZOLOPIRIDINE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |